Repligen (RGEN) Tops Q2 EPS by 9c ; Offers Guidance
Get Alerts RGEN Hot Sheet
Price: $174.55 -7.47%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.54, $0.09 better than the analyst estimate of $0.45. Revenue for the quarter came in at $204 million versus the consensus estimate of $201.47 million.
Outlook:-
FY 2026 EPS between $2.03-$2.09 vs consensus $2.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Dover raises tender offer cap to $300M, extends expiration date
- Norwegian Cruise (NCLH) PT Raised to $22 at Freedom Broker, Upgrades to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share